The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Discover how Anneo Biotech is quietly leading India's probiotic revolution, building the future of preventive healthcare.

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to continue.

The high-profile obesity drug developer priced the biotech sector’s biggest offering since 2022 and will use the proceeds to ...

In this article, we will examine the Top 8 Long-Term Biotechnology Stocks to Buy. Momentum in biotechnology stocks is accelerating after years of underperformance. The NASDAQ biotechnology stocks have ...

In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy. According to Eli Casdin, CEO of ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

On 16 December 2025, the European Commission proposed a package of measures to improve the health of EU citizens, while ensuring the long-term resilience and competitiveness of the EU health sector.